MétaCan
Menu
Back to cohort
Record W4321613175 · doi:10.1016/j.ajhg.2023.02.003

The impact of coding germline variants on contralateral breast cancer risk and survival

2023· article· en· W4321613175 on OpenAlexaff
Anna Morra, Nasim Mavaddat, Taru Muranen, Thomas U. Ahearn, Jamie Allen, Irene L. Andrulis, Päivi Auvinen, Heiko Becher, Sabine Behrens, Carl Blomqvist, Stig E. Bojesen, Manjeet K. Bolla, Hiltrud Brauch, Nicola J. Camp, Sara Carvalho, Jose E. Castelao, Melissa H. Cessna, Jenny Chang‐Claude, Georgia Chenevix‐Trench, Kristine Kleivi Sahlberg, Anne‐Lise Børresen‐Dale, Inger Torhild Gram, Karina Standahl Olsen, Olav Engebråten, Bjørn Naume, Jürgen Geisler, Grethe I.G. Alnæs, Kamila Czene, Brennan Decker, Joe Dennis, Thilo Dörk, Leila Dorling, Alison M. Dunning, Arif B. Ekici, Mikael Eriksson, D. Gareth Evans, Peter A. Fasching, Jonine D. Figueroa, Henrik Flyger, Manuela Gago-Domínguez, Montserrat García‐Closas, Willemina R.R. Geurts-Giele, Graham G. Giles, Pascal Guénel, Melanie Gündert, Eric Hahnen, Per Hall, Ute Hamann, Patricia Harrington, Wei He, Päivi Heikkilä, Maartje J. Hooning, Reiner Hoppe, Keith Humphreys, David J. Amor, Lesley Andrews, Yoland Antill, Rosemary L. Balleine, Jonathan Beesley, Ian Bennett, Michael Bogwitz, Leon Botes, Meagan Brennan, Melissa A. Brown, Michael F. Buckley, Jo Burke, Phyllis Butow, Liz Caldon, Ian Campbell, Michelle Cao, Anannya Chakrabarti, Deepa Chauhan, Manisha Chauhan, Alice Christian, Paul A. Cohen, Alison Colley, Ashley Crook, James Cui, Eliza Courtney, Margaret C. Cummings, Sarah‐Jane Dawson, Anna DeFazio, Martin Delatycki, Rebecca Dickson, Joanne Dixon, Ted Edkins, Stacey L. Edwards, Gelareh Farshid, Andrew Fellows, Georgina Fenton, Michael Field, James M. Flanagan, Peter C.C. Fong, Laura Forrest, Stephen B. Fox, Juliet D. French, Michael Friedländer, Clara Gaff, Mike Gattas, Peter George, Sian Greening, Marion Harris, Stewart Hart, John L. Hopper, Cass Hoskins, Clare Hunt, Paul A. James, Mark A. Jenkins, Alexa Kidd, Judy Kirk, Jessica Koehler, James Kollias, Sunil R. Lakhani, Mitchell Lawrence, Jason Lee, Shuai Li, Geoffrey J. Lindeman, Lara Lipton, Liz Lobb, Sherene Loi, Graham J. Mann, Deborah J. Marsh, Sue Anne McLachlan, Bettina Meiser, Roger L. Milne, Sophie Nightingale, Shona O’Connell, Sarah O’Sullivan, David Gallego‐Ortega, Nick Pachter, Jia‐Min Pang, Gargi Pathak, Briony Patterson, Amy Pearn, Ellen Pieper, Susan J. Ramus, Edwina Rickard, Bridget A. Robinson, Mona Saleh, Anita Skandarajah, Elizabeth Salisbury, Christobel Saunders, Jodi M. Saunus, Rodney J. Scott, Clare L. Scott, Adrienne Sexton, Andrew N. Shelling, Peter T. Simpson, Melissa C. Southey, Amanda B. Spurdle, Jessica Taylor, Renea A. Taylor, Heather Thorne, Alison H. Trainer, Kathy Tucker, Jane E. Visvader, Logan C. Walker, Rachael Williams, Ingrid Winship, Mary Ann Young, Milita Zaheed, Anna Jakubowska, Audrey Jung, Renske Keeman, Vessela N. Kristensen, Jan Lubiński, Mehdi Manoochehri, Siranoush Manoukian, Sara Margolin, Dimitrios Mavroudis, Anna Marie Mulligan, William G. Newman, Tjoung‐Won Park‐Simon, Paolo Peterlongo, Paul D.P. Pharoah, Valerie Rhenius, Emmanouil Saloustros, Elinor J. Sawyer, Rita K. Schmutzler, Mitul Shah, Ian Tomlinson, Thérèse Truong, Elke M. van Veen, Maaike P.G. Vreeswijk, Qin Wang, Camilla Wendt, Xiaohong R. Yang, Heli Nevanlinna, Peter Devilee, Douglas F. Easton, Marjanka K. Schmidt

Bibliographic record

VenueThe American Journal of Human Genetics · 2023
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicBRCA gene mutations in cancer
Canadian institutionsUniversity Health NetworkLunenfeld-Tanenbaum Research InstituteUniversity of TorontoMount Sinai Hospital
FundersU.S. Army Medical Research Acquisition ActivityMedical Research and Materiel CommandServicio Gallego de SaludEuropean Regional Development FundHelse Sør-Øst RHFInstituto de Salud Carlos IIICancer Council TasmaniaCancer Council VictoriaNational Health and Medical Research CouncilMedical Research CouncilProgramme Grants for Applied ResearchManchester Biomedical Research CentreU.S. ArmyHuntsman Cancer InstituteFreistaat SachsenXunta de GaliciaSyöpäsäätiöAgence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du TravailInstitut National Du CancerMinisterstwo Edukacji i NaukiDeutsche KrebshilfeUniversity of CreteStockholms Läns LandstingAssociazione Italiana per la Ricerca sul CancroHORIZON EUROPE Framework ProgrammeKuopion Yliopistollinen SairaalaKarolinska InstitutetUniversity of CambridgeMinisterio de Sanidad, Servicios Sociales e IgualdadNational Institutes of HealthGentofte HospitalDeutsche Gesetzliche UnfallversicherungNorges ForskningsrådDivision of Cancer Prevention, National Cancer InstituteNational Institute for Health and Care ResearchNational Cancer InstituteCancer Institute NSWCancerfondenHuntsman Cancer FoundationRobert Bosch StiftungBundesministerium für Bildung und ForschungNational Breast Cancer FoundationKWF KankerbestrijdingWellcome TrustCancer Research UKKreftforeningenAgence Nationale de la RechercheDeutsches KrebsforschungszentrumNIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer ResearchUniversity of UtahFondation de FranceSundhed og Sygdom, Det Frie ForskningsrådItä-Suomen YliopistoCancer Council NSWSusan G. Komen for the CureAgency for Science, Technology and ResearchCancer Council South AustraliaConsellería de Economía, Emprego e Industria, Xunta de GaliciaBundesministerium für Bildung, Wissenschaft, Forschung und TechnologieU.S. Department of Health and Human Services
KeywordsCHEK2PALB2Breast cancerOncologyInternal medicineGermlineMedicineHazard ratioConfidence intervalGermline mutationCancerGeneticsBiologyGeneMutation

Abstract

fetched live from OpenAlex

Evidence linking coding germline variants in breast cancer (BC)-susceptibility genes other than BRCA1, BRCA2, and CHEK2 with contralateral breast cancer (CBC) risk and breast cancer-specific survival (BCSS) is scarce. The aim of this study was to assess the association of protein-truncating variants (PTVs) and rare missense variants (MSVs) in nine known (ATM, BARD1, BRCA1, BRCA2, CHEK2, PALB2, RAD51C, RAD51D, and TP53) and 25 suspected BC-susceptibility genes with CBC risk and BCSS. Hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated with Cox regression models. Analyses included 34,401 women of European ancestry diagnosed with BC, including 676 CBCs and 3,449 BC deaths; the median follow-up was 10.9 years. Subtype analyses were based on estrogen receptor (ER) status of the first BC. Combined PTVs and pathogenic/likely pathogenic MSVs in BRCA1, BRCA2, and TP53 and PTVs in CHEK2 and PALB2 were associated with increased CBC risk [HRs (95% CIs): 2.88 (1.70-4.87), 2.31 (1.39-3.85), 8.29 (2.53-27.21), 2.25 (1.55-3.27), and 2.67 (1.33-5.35), respectively]. The strongest evidence of association with BCSS was for PTVs and pathogenic/likely pathogenic MSVs in BRCA2 (ER-positive BC) and TP53 and PTVs in CHEK2 [HRs (95% CIs): 1.53 (1.13-2.07), 2.08 (0.95-4.57), and 1.39 (1.13-1.72), respectively, after adjusting for tumor characteristics and treatment]. HRs were essentially unchanged when censoring for CBC, suggesting that these associations are not completely explained by increased CBC risk, tumor characteristics, or treatment. There was limited evidence of associations of PTVs and/or rare MSVs with CBC risk or BCSS for the 25 suspected BC genes. The CBC findings are relevant to treatment decisions, follow-up, and screening after BC diagnosis.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.004
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.006
Threshold uncertainty score0.020

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.004
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0000.000
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0060.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.014
GPT teacher head0.326
Teacher spread0.312 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations27
Published2023
Admission routes1
Has abstractno

Explore more

Same venueThe American Journal of Human GeneticsSame topicBRCA gene mutations in cancerFrench-language works237,207